Highest-materiality recent filing
Clearwater Analytics completes $8.4B take-private by Permira and Warburg Pincus
Stockholders receive $24.55/share cash; ~47% premium over undisturbed price on Nov 10, 2025.
Clearwater Analytics clears all regulatory approvals for merger; FIRB approval granted
Australian Treasurer granted FIRB approval for merger with GT Silver BidCo, effective June 19, 2026.
Clearwater Analytics stockholders approve merger with GT Silver BidCo; expected close Q2 2026
205,143,338 votes for, 1,387,769 against, 4,235,339 abstained on Merger Agreement adoption.
Clearwater Q1 revenue $221M (+74% YoY); adjusted EBITDA $77.4M; acquisition expected Q2 2026
Revenue $221.2M (+74% YoY); ARR $872M (+77% YoY); Adj. EBITDA $77.4M (+72% YoY).
CWAN Q4 revenue $217.5M (+72% YoY); ARR $841M (+77%); Adj EBITDA $74.1M (+78%)
Revenue $217.5M (+72% YoY); GAAP net loss $12.5M vs net income $420.3M in Q4'24.
Clearwater Analytics gets early HSR termination for GT Silver merger; Q2 2026 close expected
Early termination of HSR waiting period granted effective February 13, 2026.
Clearwater Analytics go-shop period expires with no alternative acquisition proposals
Go-shop period expired Jan 23, 2026; no alternative acquisition proposal received from any of 44 solicited parties.
Clearwater Analytics to be acquired for $8.4B, shareholders to receive $24.55 per share cash
Transaction valued at ~$8.4B; per share cash price of $24.55 represents ~47% premium over undisturbed price as of Nov 10, 2025.
Clearwater Q3 revenue $205.1M (+77% YoY); Adj EBITDA $70.7M (+84%); ARR $807.5M
Revenue $205.1M (+77% YoY); Adjusted EBITDA $70.7M (+84% YoY) with margin 34.5%.
Clearwater Analytics authorizes $100M share repurchase program
Board authorized up to $100M in repurchases of Class A common stock.
Clearwater Analytics Q2 revenue $181.9M (+70% YoY); raises FY2025 guidance
Revenue $181.9M, up 70% YoY; ARR $783.5M, up 83% YoY.
Clearwater Analytics appoints Bas NieuweWeme and Mukesh Aghi to board
Bas NieuweWeme appointed as Class I director, effective July 31, 2025; receives $40k annual cash retainer and initial RSU grant worth $350k.
Annual meeting elects three Class I directors; auditor KPMG ratified
Mukesh Aghi elected with 472,900,372.90 votes for, 3,530,909 withheld, 11,786,032 broker non-votes.
Clearwater Analytics eliminates all super-voting shares after WCAS stake drops below 5%
All outstanding super-voting Class C and Class D shares (10 votes each) auto-converted to single-vote Class B and Class A shares on June 12, 2025.
Clearwater Analytics Q1 revenue $126.9M (+24%), net income $6.9M, adjusted EBITDA $45.1M (+40%)
Q1 revenue $126.9M (+23.5% YoY); net income $6.9M vs $2.2M YoY; GAAP EPS $0.03.
Clearwater completes $1.5B acquisition of Enfusion, unifies front-to-back investment platform
Acquisition valued at ~$1.5B; Enfusion holders receive $10.87/share (cash) or 0.4676 CWAN shares, subject to proration (52% cash/48% stock).
Clearwater-Enfusion deal to close Apr 21; cash election oversubscribed at $10.87/share
Expected close on April 21, 2025, pending shareholder approval and customary conditions.
Clearwater/Enfusion set April 16 election deadline; deal expected to close April 21
Enfusion shareholders must elect form of merger consideration by 5:00 p.m. ET on April 16, 2025.
Clearwater Analytics closes acquisition of Blackstone's Bistro portfolio visualization platform
Consideration: 3,833,333 shares of Class A common stock issued at closing, plus $10M cash due by July 1, 2025.
Clearwater Analytics acquires Beacon for ~$560M and Bistro from Blackstone for $125M
Beacon acquisition: ~$560M total (60% cash, 40% stock at $30.05/share); Beacon had $44M ARR in 2024.
Clearwater & Enfusion HSR waiting period expired; deal on track for Q2 2025 close
HSR Act waiting period expired Feb 24, 2025, satisfying a key regulatory condition.
Clearwater Q4 revenue $126.5M (+27.7% YoY); guides FY2025 rev $535.5-542M; $1.5B Enfusion deal noted
Q4 revenue $126.5M (+27.7% YoY); ARR $474.9M (+25.3% YoY); net income $420.3M includes $472M one-time tax benefit from DTA release.
Clearwater Analytics to acquire Enfusion; $1.0B debt financing, $52.3M termination fee
Merger agreement signed Jan 10, 2025; Enfusion stockholders can elect mixed, stock, or cash consideration per share.
Special meeting on Dec 20, 2024: Proposal 1 (TRA Amendment) approved: 665,424,069 votes for, 5,469 against.
Selling stockholders to offer 25M shares of Clearwater Analytics in secondary offering
25M shares of Class A common stock offered by selling stockholders; company receives no proceeds.
Clearwater Q3 revenue $115.8M (+22% YoY); ARR $456.9M (+26%); TRA buyout $72.5M
Revenue $115.8M (+22.4% YoY); net income $4.8M vs loss $2.3M; Adjusted EBITDA $38.3M (+34.3%).
Clearwater Analytics adopts triennial say-on-pay vote after shareholder vote
Advisory vote: 996,106,883 shares for three years, 124,552,457 for one year, 55,004 for two years, 88,563 withheld, 8,708,695 broker non-votes.
Revenue $106.8M (+18.8% YoY); net income $0.3M vs net loss of $11.9M in Q2 2023.
Clearwater Analytics stockholders elect directors, ratify KPMG, approve say-on-pay frequency
Elected Eric Lee, Cary Davis, Andrew Young as Class III directors with >1.05B votes for each.
Clearwater Analytics selling stockholders offer 12M shares in secondary offering
Warburg Pincus and Permira affiliates sell 12M shares of Class A common stock in underwritten offering.
Clearwater Analytics Q1 revenue $102.7M (+21%); ARR $402.3M; guides FY rev $438-442M
Net income of $2.2M vs loss of $5.4M YoY; non-GAAP net income $26.2M (+48.8%).
Clearwater Analytics closes acquisition of Wilshire's risk and performance analytics solutions
Completed acquisition of Wilshire Axiom, Wilshire Atlas, Wilshire Abacus, and Wilshire iQComposite.
Clearwater Analytics to acquire Wilshire risk & performance analytics for ~$40M
Acquires Wilshire Axiom, Atlas, Abacus, and iQComposite analytics platforms for risk and performance.
Selling stockholders (Welsh, Carson, Anderson & Stowe affiliates) offer 16,250,000 shares of Class A common stock.
Clearwater Analytics Q4 revenue $99M (+20% YoY); FY 2024 guidance $431-437M revenue
Revenue $99.0M in Q4, +19.8% YoY; full year $368.2M, +21.3% YoY.
Clearwater Analytics selling stockholders offer 17M shares in secondary public offering
Selling stockholders (Welsh Carson, Permira, Warburg Pincus) to sell 17,000,000 shares of Class A common stock.
Selling stockholders include affiliates of Welsh Carson, Permira, and Warburg Pincus.
Clearwater Analytics Q3 revenue $94.7M (+24% YoY), Adj. EBITDA $28.6M (+51% YoY)
Revenue $94.7M, up 23.7% YoY; net loss narrowed to $2.3M from $3.0M.
Clearwater Analytics to host first Investor Day on Sept 7, 2023
Investor Day held at NYSE in New York City; materials to be posted on IR website after event.
Clearwater Q2 revenue $89.9M (+22% YoY); ARR $349.5M (+20%); guides FY revenue $364-366M
Q2 revenue $89.9M (+22.4% YoY); non-GAAP net income $20.0M (+50.9%); adj. EBITDA $24.8M (+30.2%).
Elected Christopher Hooper, D. Scott Mackesy, and Sandeep Sahai as Class II directors with 1.65B, 1.65B, and 1.68B votes for, respectively.
Secondary offering of 10,000,000 shares of Class A common stock by affiliates of Welsh, Carson, Anderson & Stowe.
Clearwater Analytics Q1 revenue $84.6M (+20% YoY); raises FY guidance
Revenue $84.6M vs $70.8M YoY; net loss $5.4M vs net income $0.5M; non-GAAP net income $17.6M (+38%).
Clearwater Analytics reports no material exposure to SVB receivership; affiliate client <1.5% of ARR
No deposits or direct investments at Silicon Valley Bank; no expected effect on liquidity or treasury operations.
Clearwater Analytics secondary offering of 13M shares by selling stockholders
Selling stockholders offering 13,000,000 shares of Class A common stock; over-allotment option for additional 1,950,000 shares.
Clearwater Analytics Q4 revenue $82.7M (+19% YoY); guides FY2023 revenue $361-364M
Q4 revenue $82.7M (+18.5% YoY); full year revenue $303.4M (+20.4% YoY).
Clearwater Analytics appoints WCAS managing partner Mackesy to board; President Kochansky to retire
WCAS managing partner Mackesy joins Board, replacing DeNicola, effective Dec 5.
Clearwater Analytics completes acquisition of JUMP Technology; doubles European presence
Completed acquisition of Paris-based JUMP Technology, a provider of investment management software (no financial terms disclosed).
Revenue $76.6M (+19% YoY); ARR $303.6M (+18.1%). Net loss $3.0M vs $11.4M loss prior year.
Clearwater Analytics agrees to acquire JUMP Technology for €75M to boost European expansion
Acquisition price: €75M plus up to 3.8M restricted stock units in Clearwater (CWAN) to JUMP employees/owners.
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
the directors of Merger Sub immediately prior to the Effective Time, Peter Flynn and Thomas Lafrance, were appointed as directors of the Company
Immediately thereafter, Parent, as the sole stockholder of the Company, removed all of the directors of the Company (other than Sandeep Sahai) and elected Jim Cox to serve as a director of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
Immediately thereafter, Parent, as the sole stockholder of the Company, removed all of the directors of the Company (other than Sandeep Sahai) and elected Jim Cox to serve as a director of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
Immediately thereafter, Parent, as the sole stockholder of the Company, removed all of the directors of the Company (other than Sandeep Sahai) and elected Jim Cox to serve as a director of the Company
Effective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company
the directors of Merger Sub immediately prior to the Effective Time, Peter Flynn and Thomas Lafrance, were appointed as directors of the Company
Max materiality 1.00 · Median 0.70 · Most common event m_and_a